Target intelligence / Profile preview

Presynaptic glutamate release machinery

Molecular classification
Other (multi-protein complex), Synaptic vesicle fusion complex, Presynaptic protein network
01

Overview

The "presynaptic glutamate release machinery" refers to the multi-protein complex at the presynaptic terminal of glutamatergic neurons responsible for the docking, priming, and fusion of synaptic vesicles with the plasma membrane to allow calcium-dependent exocytosis of glutamate into the synaptic cleft. Key components include SNARE proteins (such as synaptobrevin, syntaxin, and SNAP-25), calcium sensors (such as synaptotagmin), and other regulatory/adaptor proteins that organize vesicle pools and control their readiness for neurotransmitter release. The machinery is essential for reliable synaptic transmission, synaptic plasticity, and normal brain function. Its dysfunction is implicated in a range of neurological and neuropsychiatric disorders.

Other names
synaptic vesicle fusion apparatusvesicular release machinery
02

Mechanism of action

Inhibition or modulation of protein-protein interactions (e.g., SNARE complex inhibition); Manipulation of synaptic vesicle release probability (e.g., via presynaptic ion channel modulation)

03

Biological functions

Mediates neurotransmitter (glutamate) releaseRegulates synaptic vesicle docking, priming, and fusionControls synaptic plasticity, neurotransmission, and neuronal communication
04

Disease associations

Neurodegenerative disease (dysfunction contributes to synaptic pathology)Other neurological/psychiatric diseases (e.g., epilepsy, schizophrenia, autism; via altered neurotransmitter release)
05

Safety considerations

General suppression of presynaptic release machinery risks widespread neuronal dysfunction, leading to cognitive impairment, paralysis, or toxicity.
06

Interacting drugs

botulinum toxins
07

Biomarkers

synaptophysinsynaptotagmin

Beyond the preview

Go deeper on Presynaptic glutamate release machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Presynaptic glutamate release machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call